Bioabsorbable market is anticipated to grow 4250 million by 2025
What is stent?
A stent is a tiny metal device which is inserted into a blood vessel or internal duct in order to expand the vessel to prevent a blockage. This device remain in the body permanently or until removed through further surgical intervention. Bioresorbable stent is manufactured from a material that may dissolve or be absorbed in the body.
Market Segmentation of bioabsorbable stent market is provided in this report on the basis of material, absorption rate, application, end users and region.
Market Overview
Bioabsorbable market was valued approximately USD 400 million in 2016, is anticipated to grow 4250 million by 2025. Increasing risk of coronary artery and peripheral artery diseases drives the growth of this market. Moreover, there is a huge growth in both public and private funding in bioabsorbable stents. A significant growth opportunity is observed due to strong product pipelines which are expected to launch in coming years.
Market Segmentation by Material
- Polymer-Based
- Metallic
Market Segmentation by Absorption Rate
- Adult Stem Cell Kits
- Slow-Absorption
- Fast-Absorption
Market Segmentation by Application
- Coronary Artery Disease
- Peripheral Artery Disease
Market Segmentation by End Users
- Hospitals
- Cardiac Centers
Market Segmentation by Region
- North America
- Europe
- Asia Pacific
- Rest of the World
The Bioabsorbable stent market is dominated by North America. This region has witnessed a significant rise in awareness levels for the use of bioabsorbable stents in the treatment of coronary ailments. The rising prevalence of obesity, heart attacks, and other cardiac diseases are some reasons for the adoption of bioabsorbable stents. Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increasing research spending and government support from Major countries such as India, China, and Japan have attributed to the market growth.
This global market research report also discusses the major players in the bioabsorbable stent market, which include, Abbott Laboratories, Amaranth Medical Inc., REVA Medical, Inc., BIOTRONIK, Arterius Limited, Boston Scientific Corp., Elixir Medical Corporation, Johnson & Johnson, and others.
Related Reports:
Immucor, Inc. - Strategic SWOT Analysis Review
ALPCO Diagnostics - Medical Equipment - Deals and Alliances Profile
Euro-Diagnostica AB - Medical Equipment - Deals and Alliances Profile
Massachusetts General Hospital - Medical Equipment - Deals and Alliances Profile
CSA Medical Inc - Medical Equipment - Deals and Alliances Profile
Enterome Bioscience SA - Medical Equipment - Deals and Alliances Profile
Contact Us:
(+91)-9987295242
Comments
Post a Comment